Pandemic 2009 Influenza Update: Pandemrix™ data in children and adolescents from 3 to 17 years of age

GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programmes.